Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

ClinicalTrials.gov ID: NCT00642356

Public ClinicalTrials.gov record NCT00642356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An 8-week, Prospective, Randomized, Double-blind, Double-dummy, Active-controlled, Multi-center Comparison Study of the Effects of Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to test the effects of carbidopa/levodopa/entacapone compared to the effects of immediate-release carbidopa/levodopa on non-motor symptoms of end-of-dose wearing off in persons who have Parkinson's disease.

Study identification

NCT ID
NCT00642356
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis
Industry
Enrollment
14 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
May 2009 (Actual)
Completion
May 2009 (Actual)
Last update posted
Feb 18, 2011

2008 – 2009

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Xenoscience, Inc Phoenix Arizona 85004 —
South Coast Health Center Aliso Viejo California 92656 —
University of California Irvine California 92697 —
Coastal Neurological Medical Group, Inc La Jolla California 92037 —
Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Sunrise Clinical Research, Inc Hollywood Florida 33021 —
Charlotte Neurological Services Port Charlotte Florida 33952 —
Cotton O'Neil Clinic Topeka Kansas 66606 —
University of Maryland School of Medicine Baltimore Maryland 21201 —
Neurology, Inc Columbia Missouri 65201 —
Dr. John's Mercy Medical Center St Louis Missouri 63141 —
Creighton U Medical Center, Dept of Neurology Omaha Nebraska 68131 —
Parkinson's Disease & Movement Disorders Commack New York 11725 —
Central New York Research Corporation Syracuse New York 13210 —
Neurological Care of Central NY Syracuse New York 13210 —
Duke University Durham North Carolina 27705 —
Neurology Associates Monroeville Pennsylvania 15146 —
University of Pittsburg Pittsburgh Pennsylvania 15213 —
University of Texas Southwestern Dallas Texas 75390 —
University of Texas Medical School Houston Texas 77030 —
Scott & White Hospital Temple Texas 76508 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00642356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2011 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00642356 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →